The Promotion of Qidantongmai Tablet on Bone Marrow Mesenchymal Stem Cells Migrating to Ischemic Myocardium
XIE Juan,WANG Zong-ren,SONG Tie-bing,NAN Ya-yun,CHEN Jun,MA Liang,WANG Wen
DOI: https://doi.org/10.13241/j.cnki.pmb.2012.09.007
2012-01-01
Abstract:Objective:To investigate the effective of Qidantongmai tablet on Bone marrow Mesenchymal stem cells migrating to ischemic myocardium.Methods: SD rats were divided into four groups randomly,the transplantation only group,yiqi group,huoxue group,and Qidantongmai tablet group.SD rats of each group were administered with traditional Chinese medicine once everyday,respectively.It was lasted for 14 days.The model of myocardial infarction was built by ligation of the left anterior descending artery.The DIO-labeling MSCs were injected to animals through tail vein.After three days,ischemic myocardium were collected,Flow Cytometry was used to analyze the numbers of DIO-labeling cells in ischemic myocardium of every unit among each group;To observe DIO-labeling cells in myocardium frozen sections through fluorescence microscope.After 4 weeks,myocardial function of SD rats in every group were recorded by multichannel physiologic recorder,including mean arterial pressure(MAP),left ventricular peak systolic pressure(LVPSP),+LVdp/dtmax,-LVdp/dtmax.Results: The numbers of MSCs were significantly greater in Qidantongmai tablet group than that in other groups.Significant improvements of myocardial function,including MAP,LVPSP,+LVdp/dtmax,-LVdp/dtmax,in Qidantongmai tablet group prior to that in other groups.Conclusions: Qidantongmai tablet promotes Bone marrow Mesenchymal stem cells to migrate to ischemic myocardium.